The Phase-3 trials for the vaccine were conducted on 25,800 volunteers. Bharat Biotech has submitted the Phase-3 efficacy data earlier this week. Covaxin, the country’s first indigenous COVID-19 vaccine, was developed with seed strains received from the National Institute of Virology.Explained | What Phase 3 data submission of Covaxin means, how close is it to WHO approval, and comparison with other jabs
The Phase-3 trials for the vaccine were conducted on 25,800 volunteers. Bharat Biotech has submitted the Phase-3 efficacy data earlier this week. Covaxin, the country’s first indigenous COVID-19 vaccine, was developed with seed strains received from the National Institute of Virology.
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment